메뉴 건너뛰기




Volumn 623, Issue SUPPL.1, 2009, Pages

Infliximab therapy for patients with inflammatory bowel disease: 10 years on

Author keywords

Anti TNF therapy; Biological therapy; Crohn's disease; Disease out come; Endoscopy; Infliximab; Medical therapy; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CERTOLIZUMAB; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; GLUCOCORTICOID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; NATALIZUMAB; ONERCEPT; PLACEBO; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

EID: 71549161151     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.10.025     Document Type: Review
Times cited : (19)

References (99)
  • 1
    • 29244457275 scopus 로고    scopus 로고
    • Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
    • Ardizzone S., Maconi G., Russo A., Imbesi V., Colombo E., and Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55 (2006) 47-53
    • (2006) Gut , vol.55 , pp. 47-53
    • Ardizzone, S.1    Maconi, G.2    Russo, A.3    Imbesi, V.4    Colombo, E.5    Bianchi Porro, G.6
  • 5
    • 34248136340 scopus 로고    scopus 로고
    • Inflammatory bowel disease: clinical aspects and established and evolving therapies
    • Baumgart D.C., and Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Rev. Lancet 12 (2007) 1641-1657
    • (2007) Rev. Lancet , vol.12 , pp. 1641-1657
    • Baumgart, D.C.1    Sandborn, W.J.2
  • 8
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., and Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 (2006) 2275-2285
    • (2006) JAMA , vol.295 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 12
    • 12344329448 scopus 로고    scopus 로고
    • Ciclosporin use in acute ulcerative colitis: a long-term experience
    • Campbell S., Travis S., and Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur. J. Gastroenterol. Hepatol. 17 (2005) 79-84
    • (2005) Eur. J. Gastroenterol. Hepatol. , vol.17 , pp. 79-84
    • Campbell, S.1    Travis, S.2    Jewell, D.3
  • 13
    • 0028790186 scopus 로고
    • A controlled double blind study of azathioprine in the management of Crohn's disease
    • Candy S., Wright J., Gerber M., Adams G., Gerig M., and Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 37 (1995) 674-678
    • (1995) Gut , vol.37 , pp. 674-678
    • Candy, S.1    Wright, J.2    Gerber, M.3    Adams, G.4    Gerig, M.5    Goodman, R.6
  • 15
    • 0003059415 scopus 로고    scopus 로고
    • Infliximab for patients with refractory ulcerative colitis
    • Chey W.Y. Infliximab for patients with refractory ulcerative colitis. Inflamm. Bowel Dis. 7 (2001) S30
    • (2001) Inflamm. Bowel Dis. , vol.7
    • Chey, W.Y.1
  • 21
    • 0032723990 scopus 로고    scopus 로고
    • Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine
    • D'Haens G., Geboes K., and Rutgeerts P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest. Endosc. 50 (1999) 667-671
    • (1999) Gastrointest. Endosc. , vol.50 , pp. 667-671
    • D'Haens, G.1    Geboes, K.2    Rutgeerts, P.3
  • 23
    • 4744375545 scopus 로고    scopus 로고
    • Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
    • Daperno M., D'Haens G., and Van Assche G. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 60 (2004) 505-512
    • (2004) Gastrointest. Endosc. , vol.60 , pp. 505-512
    • Daperno, M.1    D'Haens, G.2    Van Assche, G.3
  • 25
    • 1842632413 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor alpha therapy and heart failure
    • Dinesh K., McMahon M., and Furst D.E. Anti-tumor necrosis factor alpha therapy and heart failure. Arthritis and Rheumatism 50 (2004) 1040-1050
    • (2004) Arthritis and Rheumatism , vol.50 , pp. 1040-1050
    • Dinesh, K.1    McMahon, M.2    Furst, D.E.3
  • 26
    • 0037379792 scopus 로고    scopus 로고
    • Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial
    • Farrell R.J., Alsahli M., Jeen Y.T., Falchuk K.R., Peppercorn M.A., and Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology 124 (2003) 917-924
    • (2003) Gastroenterology , vol.124 , pp. 917-924
    • Farrell, R.J.1    Alsahli, M.2    Jeen, Y.T.3    Falchuk, K.R.4    Peppercorn, M.A.5    Michetti, P.6
  • 27
    • 0034903792 scopus 로고    scopus 로고
    • The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
    • Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., Zinsmeister A.R., and Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 (2001) 255-260
    • (2001) Gastroenterology , vol.121 , pp. 255-260
    • Faubion Jr., W.A.1    Loftus Jr., E.V.2    Harmsen, W.S.3    Zinsmeister, A.R.4    Sandborn, W.J.5
  • 29
    • 0034214336 scopus 로고    scopus 로고
    • A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators
    • Feagan B.G., Fedorak R.N., and Irvine E.J. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N. Engl. J. Med. 342 (2000) 1627-1632
    • (2000) N. Engl. J. Med. , vol.342 , pp. 1627-1632
    • Feagan, B.G.1    Fedorak, R.N.2    Irvine, E.J.3
  • 32
    • 34547503869 scopus 로고    scopus 로고
    • Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
    • Ibsen Group
    • Frøslie K.F., Jahnsen J., Moum B.A., Vatn M.H., and Ibsen Group. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 133 (2007) 412-422
    • (2007) Gastroenterology. , vol.133 , pp. 412-422
    • Frøslie, K.F.1    Jahnsen, J.2    Moum, B.A.3    Vatn, M.H.4
  • 33
    • 0037007683 scopus 로고    scopus 로고
    • Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha
    • Gorman J., Sack K., and Davis J. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N. Engl. J. Med. 346 (2002) 1349-1356
    • (2002) N. Engl. J. Med. , vol.346 , pp. 1349-1356
    • Gorman, J.1    Sack, K.2    Davis, J.3
  • 34
    • 24144479466 scopus 로고    scopus 로고
    • Increased risk for demyelinating diseases in patients with inflammatory bowel disease
    • Gupta G., Gelfand J.M., and Lewis J.D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129 (2005) 819-826
    • (2005) Gastroenterology , vol.129 , pp. 819-826
    • Gupta, G.1    Gelfand, J.M.2    Lewis, J.D.3
  • 36
    • 3042579454 scopus 로고    scopus 로고
    • Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease
    • Hanauer S.B., Wagner C.L., and Bala M. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin. Gastroenterol. Hepatol. 2 (2004) 542-553
    • (2004) Clin. Gastroenterol. Hepatol. , vol.2 , pp. 542-553
    • Hanauer, S.B.1    Wagner, C.L.2    Bala, M.3
  • 37
    • 56449114364 scopus 로고    scopus 로고
    • A. randomized, double-blind, placebo-controlled trial of the human anti-TNF-a monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease
    • Hanauer S., Lukáš M., MacIntosh D., Rutgeerts P., Sandborn W., and Pollack P. A. randomized, double-blind, placebo-controlled trial of the human anti-TNF-a monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease. Gastroenterology 130 (2006) 323-333
    • (2006) Gastroenterology , vol.130 , pp. 323-333
    • Hanauer, S.1    Lukáš, M.2    MacIntosh, D.3    Rutgeerts, P.4    Sandborn, W.5    Pollack, P.6
  • 41
    • 71549120544 scopus 로고    scopus 로고
    • Successive treatment with cyclosporine and infliximab in severe ulcerative colitis (UC)
    • A-88
    • Leblanc S., Allez M., and Seksik P. Successive treatment with cyclosporine and infliximab in severe ulcerative colitis (UC). Gastroenterology 136 (2009) A-88
    • (2009) Gastroenterology , vol.136
    • Leblanc, S.1    Allez, M.2    Seksik, P.3
  • 42
    • 20444483170 scopus 로고    scopus 로고
    • A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
    • Lemann M., Mary J.Y., Colombel J.F., Duclos B., Soule J.C., Lerebours E., Modigliani R., and Bouhnik Y. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 128 (2006) 1812-1818
    • (2006) Gastroenterology , vol.128 , pp. 1812-1818
    • Lemann, M.1    Mary, J.Y.2    Colombel, J.F.3    Duclos, B.4    Soule, J.C.5    Lerebours, E.6    Modigliani, R.7    Bouhnik, Y.8
  • 44
    • 29144492201 scopus 로고    scopus 로고
    • Safety of infliximab and other Crohn's disease therapies - updated Treat registry data with over 10,000 patient-years of follow-up
    • A-580 (Abstract)
    • Lichtenstein G.R., Cohen R.D., and Feagan B.G. Safety of infliximab and other Crohn's disease therapies - updated Treat registry data with over 10,000 patient-years of follow-up. Gastroenterology 128 (2005) A-580 (Abstract)
    • (2005) Gastroenterology , vol.128
    • Lichtenstein, G.R.1    Cohen, R.D.2    Feagan, B.G.3
  • 45
    • 17144388945 scopus 로고    scopus 로고
    • Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease
    • Lichtenstein G.R., Yan S., Bala M., Blank M., and Sands B.E. Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease. Gastroenterology 128 (2005) 862-869
    • (2005) Gastroenterology , vol.128 , pp. 862-869
    • Lichtenstein, G.R.1    Yan, S.2    Bala, M.3    Blank, M.4    Sands, B.E.5
  • 48
    • 70349384546 scopus 로고    scopus 로고
    • Infliximab discontinuation in Crohn's disease patients in stable remission on combined therapy with immunosuppressors: a prospective ongoing cohort study
    • A-146
    • Louis E., Vernier-Massouille G., and Grimaud J.C. Infliximab discontinuation in Crohn's disease patients in stable remission on combined therapy with immunosuppressors: a prospective ongoing cohort study. Gastroenterology 136 (2009) A-146
    • (2009) Gastroenterology , vol.136
    • Louis, E.1    Vernier-Massouille, G.2    Grimaud, J.C.3
  • 49
    • 33846592386 scopus 로고    scopus 로고
    • Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
    • Mackey A.C., Green L., Liang L.C., Dinndorf P., and Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J. Ped. Gastroenterology & Nutrition 44 (2007) 265-267
    • (2007) J. Ped. Gastroenterology & Nutrition , vol.44 , pp. 265-267
    • Mackey, A.C.1    Green, L.2    Liang, L.C.3    Dinndorf, P.4    Avigan, M.5
  • 50
    • 16344369052 scopus 로고    scopus 로고
    • Intentional infliximab use during pregnancy for induction or maintenance of remission of Crohn's Disease
    • Mahadevan U., Kane S., and Sandborn W.J. Intentional infliximab use during pregnancy for induction or maintenance of remission of Crohn's Disease. Aliment. Pharmacol. Ther. 21 (2005) 733-738
    • (2005) Aliment. Pharmacol. Ther. , vol.21 , pp. 733-738
    • Mahadevan, U.1    Kane, S.2    Sandborn, W.J.3
  • 53
    • 0001607738 scopus 로고
    • Development and validation of an endoscopic index of the severity of Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
    • Mary J.Y., and Modigliani R. Development and validation of an endoscopic index of the severity of Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30 (1989) 983-989
    • (1989) Gut , vol.30 , pp. 983-989
    • Mary, J.Y.1    Modigliani, R.2
  • 54
    • 33749432435 scopus 로고    scopus 로고
    • Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
    • Maser E.A., Villela R., Silverberg M.S., and Greenberg G.R. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin. Gastroenterol. Hepatol. 4 (2006) 1248-1254
    • (2006) Clin. Gastroenterol. Hepatol. , vol.4 , pp. 1248-1254
    • Maser, E.A.1    Villela, R.2    Silverberg, M.S.3    Greenberg, G.R.4
  • 55
    • 44949098949 scopus 로고    scopus 로고
    • Cyclosporine (CsA) and infliximab (Infl) as acute salvage therapies for each other in severe steroid refractory ulcerative colitis (UC)
    • A-180
    • Maser E., Deconda D., Lichtiger S., Present D., and Kornbluth A. Cyclosporine (CsA) and infliximab (Infl) as acute salvage therapies for each other in severe steroid refractory ulcerative colitis (UC). Gastroenterology 132 (2007) A-180
    • (2007) Gastroenterology , vol.132
    • Maser, E.1    Deconda, D.2    Lichtiger, S.3    Present, D.4    Kornbluth, A.5
  • 56
    • 0025219580 scopus 로고
    • Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone
    • and the Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
    • Modigliani R., Mary J.Y., Simon J.F., Cortot A., Soule J.C., Gendre J.P., Rene E., and and the Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology 98 (1990) 811-818
    • (1990) Gastroenterology , vol.98 , pp. 811-818
    • Modigliani, R.1    Mary, J.Y.2    Simon, J.F.3    Cortot, A.4    Soule, J.C.5    Gendre, J.P.6    Rene, E.7
  • 58
    • 0028267896 scopus 로고
    • Frequency of glucocorticoid resistance and dependency in Crohn's disease
    • Munkholm P., Langholz E., Davidsen M., and Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35 (1994) 360-362
    • (1994) Gut , vol.35 , pp. 360-362
    • Munkholm, P.1    Langholz, E.2    Davidsen, M.3    Binder, V.4
  • 59
    • 0025322362 scopus 로고
    • Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation
    • Olaison G., Sjodahl R., and Tagesson C. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut 31 (1990) 325-328
    • (1990) Gut , vol.31 , pp. 325-328
    • Olaison, G.1    Sjodahl, R.2    Tagesson, C.3
  • 63
    • 33748260362 scopus 로고    scopus 로고
    • Infliximab for hospitalized patients with severe ulcerative colitis
    • Regueiro M., Curtis J., and Plevy S. Infliximab for hospitalized patients with severe ulcerative colitis. J. Clin. Gastroenterol. 40 (2006) 476-481
    • (2006) J. Clin. Gastroenterol. , vol.40 , pp. 476-481
    • Regueiro, M.1    Curtis, J.2    Plevy, S.3
  • 64
    • 34347369156 scopus 로고    scopus 로고
    • Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?
    • Rosh J.R., et al. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm. Bowel Dis. 13 (2007) 1024-1030
    • (2007) Inflamm. Bowel Dis. , vol.13 , pp. 1024-1030
    • Rosh, J.R.1
  • 73
    • 55249088369 scopus 로고    scopus 로고
    • SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
    • abstract
    • abstract. Sandborn W.J., Rutgeerts P., and Reinisch W. SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. Am. J. Gastroenterology 103 (2008) S436
    • (2008) Am. J. Gastroenterology , vol.103
    • Sandborn, W.J.1    Rutgeerts, P.2    Reinisch, W.3
  • 80
    • 0023521441 scopus 로고
    • Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
    • Schroeder K.W., Tremaine W.J., and Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 317 (1987) 1625-1629
    • (1987) N. Engl. J. Med. , vol.317 , pp. 1625-1629
    • Schroeder, K.W.1    Tremaine, W.J.2    Ilstrup, D.M.3
  • 83
    • 46749137801 scopus 로고    scopus 로고
    • Risk of lymphoma associated with anti-TNF agents for the treatment of Crohn's disease: a meta-analysis
    • A-144
    • A-144. Siegel C. Risk of lymphoma associated with anti-TNF agents for the treatment of Crohn's disease: a meta-analysis. Gastroenterology (2008)
    • (2008) Gastroenterology
    • Siegel, C.1
  • 84
    • 67049137968 scopus 로고    scopus 로고
    • Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
    • Solberg I.C., Lygren I., and Jahnsen J. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand. J. Gastroenterol. 44 (2009) 431-440
    • (2009) Scand. J. Gastroenterol. , vol.44 , pp. 431-440
    • Solberg, I.C.1    Lygren, I.2    Jahnsen, J.3
  • 85
    • 0036269445 scopus 로고    scopus 로고
    • The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial
    • St Clair E.W., Wagner C.L., and Fasanmade A.A. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism. 46 (2002) 1451-1459
    • (2002) Arthritis and Rheumatism. , vol.46 , pp. 1451-1459
    • St Clair, E.W.1    Wagner, C.L.2    Fasanmade, A.A.3
  • 92
    • 0036188187 scopus 로고    scopus 로고
    • Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy
    • Van Den Bosch F., Kruithof E., Baeten D., Herssens A., de Keyser F., Mielants H., and Veys E.M. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis and Rheumatism 46 (2002) 755-765
    • (2002) Arthritis and Rheumatism , vol.46 , pp. 755-765
    • Van Den Bosch, F.1    Kruithof, E.2    Baeten, D.3    Herssens, A.4    de Keyser, F.5    Mielants, H.6    Veys, E.M.7
  • 93
    • 13444253765 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial (ASSERT)
    • the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
    • Van der Heijde D., Dijkmans B., Geusens P., Sieper J., De Woody K., Williamson P., Braun J., and the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial (ASSERT). Arthritis Rheum. 52 (2005) 582-591
    • (2005) Arthritis Rheum. , vol.52 , pp. 582-591
    • Van der Heijde, D.1    Dijkmans, B.2    Geusens, P.3    Sieper, J.4    De Woody, K.5    Williamson, P.6    Braun, J.7
  • 97
    • 34548130215 scopus 로고    scopus 로고
    • Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
    • Vermeire S., Noman M., Van Assche G., Baert F., D'Haens G., and Rutgeerts P. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut 56 (2007) 1226-1231
    • (2007) Gut , vol.56 , pp. 1226-1231
    • Vermeire, S.1    Noman, M.2    Van Assche, G.3    Baert, F.4    D'Haens, G.5    Rutgeerts, P.6
  • 98
    • 34247588035 scopus 로고    scopus 로고
    • Linear growth improves during infliximab therapy in children with chronically active severe Crohn ́s disease
    • Walters D.T., Gilman A.R., and Griffiths A.M. Linear growth improves during infliximab therapy in children with chronically active severe Crohn ́s disease. Inflamm. Bowel Dis. 13 (2007) 424-430
    • (2007) Inflamm. Bowel Dis. , vol.13 , pp. 424-430
    • Walters, D.T.1    Gilman, A.R.2    Griffiths, A.M.3
  • 99
    • 33645129604 scopus 로고    scopus 로고
    • Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
    • Zochling J., Van der Heijde D., Dougados M., and Braun J. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann. Rheum. Dis. 65 (2006) 423-432
    • (2006) Ann. Rheum. Dis. , vol.65 , pp. 423-432
    • Zochling, J.1    Van der Heijde, D.2    Dougados, M.3    Braun, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.